3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Surgical Wound Infection
1
Skin Neoplasms
1
Skin Carcinoma
1
Postoperative Complications
1
Obesity
1
Breast Neoplasms
1
Adenocarcinoma
1
Interventions
pembrolizumab
9
cemiplimab
7
Nivolumab
7
Ipilimumab
6
Blood Specimen Collection
4
lifileucel
2
encorafenib
2
binimetinib
2
avelumab
2
aldesleukin
2
Specimen Handling
2
Niacinamide
2
Cyclophosphamide
2
toripalimab
1
tislelizumab
1
relatlimab
1
oxycodone-acetaminophen
1
lenvatinib
1
lavender oil
1
fludarabine
1
epacadostat
1
durvalumab
1
dostarlimab
1
brodalumab
1
atezolizumab
1
Water
1
Vitamin A
1
Tissue Banks
1
Surgical Procedures, Operative
1
Sunscreening Agents
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Skin Neoplasms
×
Negative-Pressure Wound Therapy
×
90 days
×
Clear all
NCT07040683
2026-05-28
LEGS
Region Skane
Phase NA
Recruiting
242 enrolled